Esophageal Cancer Market Size Estimates, Share Analysis, Growth Factors | Forecast till 2023 - PowerPoint PPT Presentation

View by Category
About This Presentation

Esophageal Cancer Market Size Estimates, Share Analysis, Growth Factors | Forecast till 2023


Global Esophageal Cancer Market is expected to Reach USD 1,000.1 million by the year 2023, according to Market Research Future (MRFR) Analysis. The global market research report provides in-depth industry analysis with free additional customization, including the impact of the COVID-19 pandemic. – PowerPoint PPT presentation

Number of Views:2


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Esophageal Cancer Market Size Estimates, Share Analysis, Growth Factors | Forecast till 2023

Esophageal Cancer Market
Industry Analysis, Size Estimation, Share, Demand
Analysis Forecast to 2023
Esophageal Cancer Market
Esophageal Cancer Market Overview
Rated the sixth most common type of cancer
affecting patients, esophageal cancer is
responsible for numerus deaths worldwide. Tobacco
and alcohol consumption, or certain dietary
habits can lead to probabilities of attaining the
disease. With advances in treatment, diagnostics,
and surgical techniques, the prognosis rate of
esophageal cancer has improved considerably over
the ears. In addition, increase in survival
rates, detection at an early stage, and
transformation in the field of drug development
have all worked in favor of the global esophageal
cancer market. The global esophageal market size
can touch USD 1000.1 million by 2023, as per the
report by Market Research Future
(MRFR). Historically, esophageal cancer had
limited treatment options. However, recent
treatment advances are aiding patients to opt for
treatment options that can possibly help them
live longer with less side effects. Intensive RD
activities and clinical trials are being carried
out at an accelerated pace. Combination of
various therapies such as chemotherapy with
immunotherapy have demonstrated significant
improvement in response rates. Of late, the FDA
has also been approving more immunotherapy drugs
for a variety of oncological disorders, which is
likely to uplift the development of the
esophageal cancer market. The market is touted to
accrue revenue at 8.7 CAGR from 2017 to 2023
(forecast period).
Esophageal Cancer Market
  • Esophageal Cancer Market Segmentation
  • The global esophageal cancer market has been
    segmented based on type, phase, and treatment.
  • By type, the esophageal cancer market has been
    segmented into esophageal squamous-cell
    carcinoma, esophageal adenocarcinoma, and others.
    The esophageal squamous-cell carcinoma segment is
    predicted to gain significant revenue in the
    coming years. It held close to 65 market share
    in 2016.
  • By phase, the esophageal cancer market has been
    segmented into phase I, phases II, and phases
  • By treatment, the esophageal cancer market has
    been segmented into surgery, chemotherapy and
    radiotherapy and others.
  • Get Free Sample of Report _at_  https//www.marketres

Esophageal Cancer Market
Esophageal Cancer Market Regional Analysis
Region-wise, the esophageal cancer market has
been segmented into North America, the Middle
East Africa (MEA), Asia Pacific (APAC), and
Europe. With numerous cases of esophageal
cancer, North America has commanded the leading
position in the global esophageal cancer market.
The population of the region is highly addicted
to tobacco, which remains among the prime causes
of esophageal cancer. High government support,
high healthcare expenditure, and favorable
reimbursement landscape is providing impetus to
the growth of the North America market. The US
has major contribution to make in the North
America market. Robust healthcare infrastructure
and the presence of a wide population base
supports the growth of the market. Intensive RD
activities in Europe is driving the growth of the
esophageal cancer market in Europe. The expansion
of the APAC market can be attributed to the
surging incidence rate of esophageal cancer and
large unmet needs in the region.
Browse Report _at_ https//www.marketresearchfuture.
Esophageal Cancer Market
Esophageal Cancer Market Competitive Analysis
Amgen Inc. (U.S.), Boehringer Ingelheim GmbH
(Germany), Johnson Johnson (U.S.), Eli Lilly
and Company (U.S.), Merck Co., Inc. (U.S.), F.
Hoffmann-La Roche (Switzerland), Novartis AG
(Switzerland), GlaxoSmithKline Plc. (U.K),
Bristol-Myers Squibb (U.S.), Bristol-Myers Squibb
Company (U.S.), and Gilead Sciences, Inc. (U.S.)
are the eminent players in the global esophageal
cancer market. August 2019 - A new immunotherapy
drug has been approved by the U.S. Food and Drug
Administration (FDA) aimed at treating esophageal
cancer. Dubbed as Keytruda", the new
immunotherapy drug pembrolizumab has exhibited
its efficiency in reducing the risk of fatality
in esophageal cancer patients by 31 in clinical
trials. The treatment would be beneficial for
those patients who are unresponsive to
chemotherapy. Keytruda is the result of
aggressive RD by the leading pharmaceutical
company, Merck Co.
Ask Questions To The Experts _at_
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit or contact us at Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
(No Transcript)